Patents by Inventor Douglas N. Henry

Douglas N. Henry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6416643
    Abstract: A method for spectrographically providing a chemical profile of mammalian cells in vitro using capillary (10) electrophoresis is described. The method enables rapid determination of the chemicals, especially human cell metabolites, in the case of diabetes. The method is rapid, efficient and reproducible and enables the diagnosis of the progress of a disease at the cellular level.
    Type: Grant
    Filed: February 29, 2000
    Date of Patent: July 9, 2002
    Assignee: Board of Trustees of Michigan State University
    Inventors: Douglas N. Henry, Patrick F. Dillon
  • Patent number: 6113763
    Abstract: A method for spectrographically providing a chemical profile of mammalian cells in vitro using capillary (10) electrophoresis is described. The method enables rapid determination of the chemicals, especially human cell metabolites, in the case of diabetes. The method is rapid, efficient and reproducible and enables the diagnosis of the progress of a disease at the cellular level.
    Type: Grant
    Filed: October 29, 1997
    Date of Patent: September 5, 2000
    Assignee: Board of Trustee operating Michigan State University
    Inventors: Douglas N. Henry, Patrick F. Dillon
  • Patent number: 6074822
    Abstract: A test method and test kit for determining a risk of diabetic complications based upon abnormal aldose reductase genetic material expression is described. Cells isolated from a patient which exhibit elevated levels of aldose reductase genetic material expression at pathophysiologic levels of glucose (about 20 mM) which can occur commonly in the cells of diabetic patients are evaluated based upon a level of expression of DNA or RNA in the cells with the glucose at the pathophysiologic level. The cells can be used to isolate DNA or RNA for a probe which detects the abnormal aldose reductase gene expression. The method can be used to determine when particular aldose reductase inhibitors can be effective for a particular patient.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: June 13, 2000
    Assignee: Board of Trustees operating Michigan State University
    Inventor: Douglas N. Henry